Table 2.
Comparison of quality of life C-30 functional scales-physical function, within and between control group and experimental group of breast cancer patients undergoing chemotherapy
| Chemotherapy cycles and number of patients in the control and experimental groups | Physical function | |||
|---|---|---|---|---|
| Mean±SD Median (minimum - maximum) | Difference (95% CI) | P* Mann-Whitney Test | ||
| Control group | Experimental group | |||
| Cycle I (n=100) | 72.30±8.49 73.33 (60-86.66) | 72.63±5.71 73.33 (60-80) | −0.33 (−3.22-2.56) | 0.503 |
| Control=52 | ||||
| Experiment=48 | ||||
| Cycle II (n=98) | 64.96±15.36 66.66# (20-93.33) | 71.06±13.06 73.33 (33.33-100) | −6.09 (−11.83-−0.35) | 0.0523 |
| Control=51 | ||||
| Experiment=47 | ||||
| Cycle III (n=96) | 60.26±18.01 60# (13.33-93.33) | 69.13±15.41 73.33 (20-93.33) | −8.86 (−15.68-−2.03) | 0.0074** |
| Control=50 | ||||
| Experiment=46 | ||||
| Cycle IV (n=93) | 57.73±23.02 60# (13.33-100) | 66.37±14.53 70# (20-86.66) | −8.64 (−16.59-−0.69) | 0.0720 |
| Control=47 | ||||
| Experiment=46 | ||||
| Cycle V (n=84) | 54.28±19.51 53.33# (20-93.33) | 69.84±15.94 73.33 (33.33-93.33) | −15.55 (−23.28-−7.82) | 0.0002** |
| Control=42 | ||||
| Experiment=42 | ||||
| Cycle VI (n=83) | 53.80±20.42 53.33# (6.66-100) | 68.45±16.26 73.33 (26.66-93.33) | −14.64 (−22.72-−6.57) | 0.0007** |
| Control=42 | ||||
| Experiment=41 | ||||
| P value Friedman test | <0.0001** | <0.0001** | ||
*P<0.05, **Significant, #Wilcoxon signed-rank test (significant). SD: Standard deviation, CI: Confidence interval